Company

Prenetics

Nasdaq-listed health and diagnostics company, parent of IM8, a fast-growing supplement brand co-founded with David Beckham

Food & Consumer GoodsHealthcare & Biotech

People

Danny Yeungceo

Funding History

Jul 20, 2026

Prenetics (parent of IM8) received a $1B growth commitment from General Catalyst's Customer Value Fund to finance customer acquisition for the IM8 supplement brand.

1B

Investors

General Catalyst

News

Interviews (1)

IM8 hits $200M ARR in 18 months with David Beckham and a $1B General Catalyst growth commitment
20 Jul 2026